deltatrials
Completed PHASE2 NCT01887223

Transconjunctival Needling Revision Versus Medical Treatment

Early Transconjunctival Needling Revision With 5-fluorouracil Versus Medical Treatment in Encapsulated Blebs: a 12-month Prospective Study

Sponsor: University of Sao Paulo General Hospital

Updated 7 times since 2017 Last updated: Jun 26, 2013 Started: May 31, 2010 Primary completion: Jun 30, 2011 Completion: Jun 30, 2011

A PHASE2 clinical study on Primary Open Angle Glaucoma, this trial is completed. The trial is conducted by University of Sao Paulo General Hospital and has accumulated 7 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

7 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

Show 2 earlier versions
  1. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Sao Paulo General Hospital
Data source: University of Sao Paulo General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • São Paulo, Brazil